Clinical Investigations: Investigators' Responsibilities for Medical Devices
Summary
MHRA published guidance clarifying clinical investigators' responsibilities when conducting medical device investigations in the UK. The guidance covers submission requirements, MHRA's approval process, device labeling standards, and documentation requirements. This is informational guidance without new legal obligations.
What changed
This MHRA guidance document provides comprehensive instructions for clinical investigators on meeting regulatory requirements for medical device investigations. The guidance outlines what must be included in submissions notifying MHRA of planned clinical investigations, including details on the approval process, conduct standards, device labeling requirements, and required documentation.
Clinical investigators and manufacturers conducting medical device research in the UK should review this guidance to ensure their investigation protocols and submissions align with MHRA expectations. The document serves as a practical reference for understanding regulatory requirements rather than establishing new obligations. No specific compliance deadlines or penalties are mentioned.
What to do next
- Review the guidance to ensure clinical investigation submissions meet MHRA requirements
- Verify all required documentation is prepared according to the guidance
- Update investigation protocols to align with MHRA labeling and conduct standards
Source document (simplified)
Guidance
Clinical investigations: investigators' responsibilities
How to make sure your clinical investigation will meet the MHRA's requirements for medical devices.
From: Medicines and Healthcare products Regulatory Agency Published 30 March 2026 Get emails about this page
Documents
Guidance for clincal investigators
HTML
Details
This guidance helps clinical investigators understand what needs to be included in a submission notifying the MHRA of a manufacturer’s plans to undertake a clinical investigation, including our approval process, conduct, labelling of devices and what documentation you need to provide.
Updates to this page
Published 30 March 2026
Sign up for emails or print this page
Get emails about this page Print this page
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when MHRA Guidance & Safety publishes new changes.